Diagnosis-based risk adjustment for medicare prescription drug plan payments.
John M. Robst, Jesse M. Levy, Melvin J. Ingber
Abstract
John M. Robst, Jesse M. Levy, Melvin J. Ingber
Abstract
The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees.
OpenAlex reports 63 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees.
Key concepts: Prescription drug, Medical prescription, Medicare Part D, Medicaid, Medicine, Medicare Advantage, Payment, Actuarial science